Global Early Phase Clinical Trial Outsourcing Market Growing at 7.9% CAGR Through 2034
According to a new report from Intel Market Research, the global Early Phase Clinical Trial Outsourcing Market was valued at USD 15.2 billion in 2025 and is projected to reach USD 28.7 billion by 2034, growing at a CAGR of 7.9% during the forecast period (2026–2034). This expansion is driven by rising demand for fully integrated trial design, real-time data insights, biomarker-driven...
0 Comentários 0 Compartilhamentos 94 Visualizações 0 Anterior